Skip to main content
Caplight Logo









Beijing Cygenta Biotech Co., Ltd.

Beijing Cygenta Biotech Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://cgtcdmo.com

Last Round

Series C

Extension

Apr 19, 2023

Total Funding Raised

$116.79M

Company Overview

Beijing Cygenta Biotech Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series C Extension round in April 2023.

Beijing Cygenta Biotech Co., Ltd. is a biotechnology company that provides contract development and manufacturing organization (CDMO) services for gene and cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Compliance, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Beijing Cygenta Biotech Co., Ltd. Comparables

Compare Beijing Cygenta Biotech Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing Cygenta Biotech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
uBriGene Biosciences
88%
OBiO Technology
83%
Porton Pharma Solutions Ltd.
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Beijing Cygenta Biotech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionApr 19, 2023
Series CSep 26, 2022
Series BSep 16, 2021
Series ADec 15, 2020
Early FundingOct 21, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Beijing Cygenta Biotech Co., Ltd. Investors

Notable investors and investment history

Beijing Cygenta Biotech Co., Ltd. investors
InvestorRounds
IDG CapitalSeries C, Series B
中信金石投资有限公司Series C
Beijing Fangfu Venture Capital ManagementSeries C Extension, Series A, Series B, Series C
Yuanchuang Duoying Investment GroupSeries C
Huagai CapitalSeries B, Series C, Series A
Addor CapitalSeries B
Chiron VenturesEarly Funding
Book a demo to see all 10 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2023

    $22M round led by Guotai Junan Innovation Investment.

  • Sep 26, 2022

    $43M round led by CLSA Capital Partners and 中信金石投资有限公司.

Book a demo to see all signals

For institutional investors. Book with your work email.

Beijing Cygenta Biotech Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Beijing Cygenta Biotech Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Beijing Cygenta Biotech Co., Ltd.'s valuation, stock price, and market status.

Is Beijing Cygenta Biotech Co., Ltd. a public or private company?

Beijing Cygenta Biotech Co., Ltd. is a private company.

What is the current stock price of Beijing Cygenta Biotech Co., Ltd.?

Beijing Cygenta Biotech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Beijing Cygenta Biotech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Beijing Cygenta Biotech Co., Ltd. worth (valuation)?

Valuation information for Beijing Cygenta Biotech Co., Ltd. is not publicly available.

Can I buy Beijing Cygenta Biotech Co., Ltd. stock?

Beijing Cygenta Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Beijing Cygenta Biotech Co., Ltd.'s last funding round?

Beijing Cygenta Biotech Co., Ltd.'s most recent funding round was Series C Extension on April 19, 2023.

Who are the main investors in Beijing Cygenta Biotech Co., Ltd.?

Key investors in Beijing Cygenta Biotech Co., Ltd. include IDG Capital, 中信金石投资有限公司, Huagai Capital, Addor Capital, 国泰君安创新投资有限公司.

Will Beijing Cygenta Biotech Co., Ltd. IPO soon?

No public IPO plans have been announced for Beijing Cygenta Biotech Co., Ltd..

How can I track Beijing Cygenta Biotech Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Beijing Cygenta Biotech Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersBeijing
Employee Range1
Year FoundedN/A
Last FundingApr 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?